TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TXMD on Nasdaq
Shares outstanding
11,549,491
Price per share
$2.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,384,889
Total reported value
$5,517,397
% of total 13F portfolios
0%
Share change
+81,101
Value change
+$146,413
Number of holders
41
Price from insider filings
$2.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Clearline Capital LP 5.5% $705,096 635,222 Clearline Capital LP 31 Dec 2024

As of 31 Dec 2025, 41 institutional investors reported holding 3,384,889 shares of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD). This represents 29% of the company’s total 11,549,491 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Rubric Capital Management LP 10% 1,192,191 0% 0.02% $1,943,271
Clearline Capital LP 5.5% 635,222 0% 0.08% $1,035,412
VANGUARD GROUP INC 3.4% 397,056 +5.4% 0% $647,201
Tejara Capital Ltd 3% 350,852 +1.9% 0.24% $571,889
ADAR1 Capital Management, LLC 1.8% 209,210 0% 0.03% $341,012
MORGAN STANLEY 1.1% 129,217 -1% 0% $210,624
BlackRock, Inc. 1% 116,132 0% 0% $189,295
GEODE CAPITAL MANAGEMENT, LLC 0.92% 106,100 -2.7% 0% $172,984
RENAISSANCE TECHNOLOGIES LLC 0.84% 96,500 +172% 0% $157,295
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.3% 35,164 0% $57,317
STATE STREET CORP 0.26% 30,100 0% 0% $49,063
CITADEL ADVISORS LLC 0.24% 28,240 -18% 0% $46,031
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.15% 17,000 -50% 0% $27,710
NORTHERN TRUST CORP 0.14% 16,448 -0.05% 0% $26,811
OSAIC HOLDINGS, INC. 0.08% 9,297 +936% 0% $15,153
FMR LLC 0.07% 8,290 +0.01% 0% $13,513
Tower Research Capital LLC (TRC) 0.02% 2,471 -9.6% 0% $4,028
GROUP ONE TRADING LLC 0.01% 1,596 0% $2,601
UBS Group AG 0.01% 1,114 +208% 0% $1,815
NATIONAL BANK OF CANADA /FI/ 0.01% 610 -9% 0% $976
Smartleaf Asset Management LLC 0.01% 601 0% $986
JPMORGAN CHASE & CO 0% 293 0% 0% $477
SBI Securities Co., Ltd. 0% 255 0% 0% $416
US BANCORP \DE\ 0% 246 0% 0% $401
BNP PARIBAS FINANCIAL MARKETS 0% 226 0% 0% $368

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,384,889 $5,517,397 +$146,413 $1.63 41
2025 Q3 3,303,788 $3,542,705 +$51,253 $1.08 43
2025 Q2 3,255,627 $3,776,528 -$96,760 $1.16 39
2025 Q1 3,343,589 $3,092,849 -$161,728 $0.92 39
2024 Q4 3,528,745 $3,034,778 +$127,744 $0.86 38
2024 Q3 3,379,026 $5,609,223 -$32,659 $1.66 34
2024 Q2 3,408,566 $5,487,879 -$167 $1.61 34
2024 Q1 3,377,053 $7,732,812 +$286,534 $2.29 43
2023 Q4 3,251,877 $7,316,577 -$358,133 $2.25 36
2023 Q3 2,987,555 $9,324,433 +$112,168 $3.02 36
2023 Q2 3,031,054 $12,488,021 -$296,992 $4.12 40
2023 Q1 3,115,140 $11,682,289 -$1,635,363 $3.75 38
2022 Q4 3,475,915 $19,431,091 +$6,039,029 $5.59 43
2022 Q3 2,070,807 $13,750,198 -$489,469 $6.64 29
2022 Q2 1,993,507 $19,835,726 +$19,831,622 $9.95 36
2022 Q1 10,800 $4,104 +$304 $0.38 2
2021 Q4 10,000 $3,555 $0.36 1